Title:
TAFIa阻害剤としての置換されたイミダゾール
Document Type and Number:
Japanese Patent JP4778531
Kind Code:
B2
Abstract:
The present invention provides compounds of formula (I). These compounds are a class of TAFIa inhibitors, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases and those conditions which benefit from maintaining or enhancing bradykinin levels in the body.
Inventors:
Allerton, Charlotte Moira Nofor
Bragg, Julian
Van Age, Mark Edward
Steel, john
Bragg, Julian
Van Age, Mark Edward
Steel, john
Application Number:
JP2008045382A
Publication Date:
September 21, 2011
Filing Date:
February 27, 2008
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
C07D233/64; A61K31/00; A61K31/415; A61K31/4172; A61K31/4178; A61K31/454; A61K31/551; A61K45/06; A61L33/00; A61P1/00; A61P1/04; A61P7/02; A61P9/00; A61P9/06; A61P9/10; A61P11/00; A61P11/06; A61P15/08; A61P17/00; A61P17/02; A61P17/04; A61P17/06; A61P19/02; A61P21/00; A61P25/02; A61P25/16; A61P25/28; A61P27/02; A61P29/00; A61P35/00; A61P37/08; A61P41/00; A61P43/00; C07D233/54; C07D401/06; C07D401/12; C07D403/12; C07D417/06; A61K; A61P; C07D
Foreign References:
| WO1988003927A2 |
Attorney, Agent or Firm:
Yoshinobu Murofushi